Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis
NCT: NCT07790276 · NOT_YET_RECRUITING
Brief Summary
This prospective, multicenter observational study will evaluate glucose profiles using continuous glucose monitoring (CGM) in 100 adults with diabetes receiving peritoneal dialysis (PD) or planning to start PD within 3 months. The study will examine associations between CGM metrics and PD regimen, glucose-lowering treatment, conventional glycemic markers, dialysis-related measures, and clinical outcomes including glycemic emergencies, hospitalizations, cardiovascular events, and mortality over 12 months.
Frequently Asked Questions
What is Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis?
Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis is a clinical trial registered under NCT07790276. Current status: NOT_YET_RECRUITING.
What is the status of NCT07790276?
The current status of NCT07790276 (Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis) is: NOT_YET_RECRUITING.
When did Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis start?
Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis started on 2026-08-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.